FRAS1 and metastatic prostate carcinoma: A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer [41], and FRAS1 mRNA was highly expressed in tissues rich in muscle cells or fibers in this study.